Caspase-1 also cleaves gasdermin D (GSDMD) to relieve autoinhibition of its N-terminal domain (GSDMD-N), which exhibits increased levels in human and experimental NASH [12]. This evidence concerns the gene GSDMD and metabolic dysfunction-associated steatohepatitis.